Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

REGEN BIOPHARMA, INC. (RGBP) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

REGEN BIOPHARMA, INC. (RGBP), most recent 12 months reported: revenue $236.56K, net loss $1.19M. Latest balance sheet on file: liquid cash $239, total debt $891.76K, net cash -$891.52K. From SEC filings. Others in Pharmaceutical Preparations: Can-Fite BioPharma Ltd. · PROVECTUS BIOPHARMACEUTICALS, INC. · CervoMed Inc. · Allarity Therapeutics, Inc. · Clene Inc. · LEXARIA BIOSCIENCE CORP. · Lisata Therapeutics, Inc. · Serina Therapeutics, Inc.

Stock screener

Watchlist